Mycobacterium triplex pulmonary disease with acquired macrolide resistance in immunocompetent patients

Clin Microbiol Infect. 2018 Jun;24(6):671-672. doi: 10.1016/j.cmi.2017.12.018. Epub 2018 Jan 5.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-Bacterial Agents / adverse effects*
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Drug Resistance, Multiple, Bacterial*
  • Female
  • Humans
  • Immunocompetence
  • Lung / diagnostic imaging
  • Lung / microbiology
  • Lung Diseases / drug therapy
  • Macrolides / adverse effects*
  • Macrolides / therapeutic use
  • Middle Aged
  • Mycobacterium Infections, Nontuberculous / diagnosis
  • Mycobacterium Infections, Nontuberculous / drug therapy*
  • Mycobacterium avium Complex / drug effects
  • Nontuberculous Mycobacteria / drug effects*
  • Nontuberculous Mycobacteria / genetics
  • Nontuberculous Mycobacteria / isolation & purification
  • RNA, Ribosomal, 16S / genetics
  • Radiography
  • Sputum / microbiology
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Macrolides
  • RNA, Ribosomal, 16S